Abortion pills at pharmacies could face legal quagmires; pathologists who study pregnancy loss walk a thin line

Federal regulators' green light for pharmacists to dispense abortion pills is crashing into legal questions and simmering court battles. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by     'Hot mess': Abortion pills at pharmacies could face legal quagmires, especially in restrictive states By Sarah Owermohle Allen G. Breed/AP Federal regulators' green light for pharmacists to dispense abortion pills is crashing into legal questions and simmering court battles. Read More In a post-Dobbs world, pathologists who study pregnancy loss walk a thin line between medicine and the law By Eleanor Cummins Sandy Huffaker for STAT Placentas can hold important insights into pregnancy loss. Pathologists are worried about how law enforcement might misuse that information. Read More A new study links social media use to changes in teen brains. Is that a bad thing? By Ryan Fitzgerald Lauren DeCicca/Getty Images A recent study adds to a growing body of research that suggests social media's impact on young people can't categorized as just good or bad. Read More Sponsored Insight by STAT Madness Apply for STAT Madness! Has your institution innovated in ways worth celebrating? Submit your application to be considered for our bracket-style tournament to find the best innovations in science and medicine here. STAT+: Will the European Union give vouchers to pharma to develop badly needed antibiotics? By Ed Silverman Melissa Brower/Centers for Disease Control and Prevention via AP A battle is brewing in the European Union over whether to give vouchers to pharma to develop badly needed antibiotics. Read More Opinion: Upcoding: one reason Medicare Advantage companies pay clinicians to make home health checkups By Robert M. Kaplan and Paul Tang Adobe Upcoding — adding extra diagnoses to patients' charts — by Medicare Advantage plans will cost Medicare $200 billion over the next decade. Read More With Gates Foundation backing, a health tech company aims to speed diagnosis of some neglected tropical diseases By Brittany Trang STR/AFP via Getty Images VisualDx aims to speed diagnosis of neglected tropical diseases such as trachoma and hookworm. Read More Opinion: Medical school rankings need a new metric: economic mobility index By David Lenihan Adobe Adding an economic mobility index to the calculation of medical school rankings would better identify schools' societal impact. Read More Listen: How blockbusters get made, new vaccines for RSV, and mRNA's Q score By Damian Garde and Meg Tirrell and Adam Feuerstein Journalist Nathan Vardi joins us to talk about his new book delving into the race to develop the lifesaving cancer drug now called Imbruvica. Read More Thursday, January 19, 2023       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2023, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser